Human glomerular mesangial cells inactivate leukotriene B4 by reduction into dihydro-leukotriene B4 metabolites. 1990

V Kaever, and J Bruuns, and J Wunder, and B Damerau, and G Zimmer, and J Fauler, and K Wessel, and J Floege, and N Topley, and H Radeke
Institutes of Molecular Pharmacology, Medical School, Hannover, F.R.G.

Due to its potent chemotactic properties leukotriene B4 is an important mediator of inflammatory reactions. Cultured human kidney mesangial cells converted exogenously added leukotriene B4 efficiently into three different more lipophilic metabolites, two of them probably representing dihydro-leukotriene B4 isomers. This represents an alternative metabolic pathway, in contrast to leukotriene B4 omega-oxidation found in human polymorphonuclear leukocytes. Both dihydro-leukotriene B4 isomers had nearly completely lost their ability to induce leukocyte chemotaxis as compared to leukotriene B4.

UI MeSH Term Description Entries
D007975 Leukotriene B4 The major metabolite in neutrophil polymorphonuclear leukocytes. It stimulates polymorphonuclear cell function (degranulation, formation of oxygen-centered free radicals, arachidonic acid release, and metabolism). (From Dictionary of Prostaglandins and Related Compounds, 1990) 5,12-HETE,5,12-diHETE,LTB4,Leukotriene B,Leukotriene B-4,Leukotrienes B,5,12 HETE,5,12 diHETE,B-4, Leukotriene,Leukotriene B 4
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002634 Chemotaxis, Leukocyte The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. Leukotaxis,Leukocyte Chemotaxis
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005920 Glomerular Mesangium The thin membranous structure supporting the adjoining glomerular capillaries. It is composed of GLOMERULAR MESANGIAL CELLS and their EXTRACELLULAR MATRIX. Mesangium, Glomerular,Mesangial Extracellular Matrix,Extracellular Matrices, Mesangial,Extracellular Matrix, Mesangial,Glomerular Mesangiums,Matrices, Mesangial Extracellular,Matrix, Mesangial Extracellular,Mesangial Extracellular Matrices,Mesangiums, Glomerular
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

V Kaever, and J Bruuns, and J Wunder, and B Damerau, and G Zimmer, and J Fauler, and K Wessel, and J Floege, and N Topley, and H Radeke
September 1989, Prostaglandins, leukotrienes, and essential fatty acids,
V Kaever, and J Bruuns, and J Wunder, and B Damerau, and G Zimmer, and J Fauler, and K Wessel, and J Floege, and N Topley, and H Radeke
September 1991, Journal of leukocyte biology,
V Kaever, and J Bruuns, and J Wunder, and B Damerau, and G Zimmer, and J Fauler, and K Wessel, and J Floege, and N Topley, and H Radeke
December 1993, The Journal of biological chemistry,
V Kaever, and J Bruuns, and J Wunder, and B Damerau, and G Zimmer, and J Fauler, and K Wessel, and J Floege, and N Topley, and H Radeke
April 1988, FEBS letters,
V Kaever, and J Bruuns, and J Wunder, and B Damerau, and G Zimmer, and J Fauler, and K Wessel, and J Floege, and N Topley, and H Radeke
June 1987, Biochemical and biophysical research communications,
V Kaever, and J Bruuns, and J Wunder, and B Damerau, and G Zimmer, and J Fauler, and K Wessel, and J Floege, and N Topley, and H Radeke
May 1990, Biochimica et biophysica acta,
V Kaever, and J Bruuns, and J Wunder, and B Damerau, and G Zimmer, and J Fauler, and K Wessel, and J Floege, and N Topley, and H Radeke
April 1989, The Journal of biological chemistry,
V Kaever, and J Bruuns, and J Wunder, and B Damerau, and G Zimmer, and J Fauler, and K Wessel, and J Floege, and N Topley, and H Radeke
October 1986, Kidney international,
V Kaever, and J Bruuns, and J Wunder, and B Damerau, and G Zimmer, and J Fauler, and K Wessel, and J Floege, and N Topley, and H Radeke
July 2003, The Journal of biological chemistry,
V Kaever, and J Bruuns, and J Wunder, and B Damerau, and G Zimmer, and J Fauler, and K Wessel, and J Floege, and N Topley, and H Radeke
January 1995, Thorax,
Copied contents to your clipboard!